The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Neuropsychiatric Systemic Lupus Erythematosus
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
Lupus Landmark Study: A Prospective Registry and Biorepository
-
University of Alabama at Birmingham, Birmingham, Alabama, United States, 35205
Wallace Rheumatic Studies Center, Los Angeles, California, United States, 90048
Emory University, Atlanta, Georgia, United States, 30322
University of Chicago Medicine, Chicago, Illinois, United States, 60637
University of Massachusetts Memorial Health, Worcester, Massachusetts, United States, 01605
Northwell Health, New York, New York, United States, 11021
SUNY Upstate, Syracuse, New York, United States, 13210
UNC Chapel Hill, Chapel Hill, North Carolina, United States, 27599
UT Southwestern Medical Center, Dallas, Texas, United States, 75390
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 110 Years
ALL
No
Lupus Research Alliance,
Sam Lim, MD, MPH, PRINCIPAL_INVESTIGATOR, Emory University
Arezou Khosroshahi, MD, PRINCIPAL_INVESTIGATOR, Emory University
Alfred Kim, MD, PhD, PRINCIPAL_INVESTIGATOR, Washington University School of Medicine
2033-12